1-4 of 4
Shinichi Kitada, MD, PhD
Close
Sort by
Journal Articles

Comparison of in Vitro Apoptotic Response of Chronic Lymphocytic Leukemia (CLL) Cells to Bcl-2 Antagonist ABT-737 and IAP Antagonist BV6.

Shinichi Kitada, MD, PhD, Ryuji Yamaguchi, Ph.D., Laura Z. Rassenti, PhD, Thomas J. Kipps, MD, PhD, John C. Reed, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4386.
https://doi.org/10.1182/blood.V114.22.4386.4386
Published: 2009
Journal Articles

Bcl-2 Antagonist ApoGossypol (NSC736630) Displays Single-Agent Activity in Bcl-2 Transgenic Mice and Has Superior Efficacy and Pharmacology with Less Toxicity Compared to Gossypol (NSC19048).

Shinichi Kitada, MD, PhD, Lee Jia, Ph.D., Lori C. Coward, Ph.D., Greg S. Gorman, Ph.D., Patricia Noker, Ph.D., Maurizio Pellecchia, Ph.D., John C. Reed, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2487.
https://doi.org/10.1182/blood.V108.11.2487.2487
Published: 2006
Journal Articles

R-(−)-Gossypol (AT101) Binds to Bcl-2 Family Proteins and Induces Apoptosis in CLL.

Carlos E. Prada, MD, Januario E. Castro, MD, Dayong Zhai, PhD, Shinichi Kitada, MD, PhD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2978.
https://doi.org/10.1182/blood.V106.11.2978.2978
Published: 2005
Journal Articles

BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α.

Mitsufumi Nishio, MD, PhD, Nobuhiro Tsukada, MD, PhD, Shinichi Kitada, MD, PhD, Junko Ohata, MD, PhD, Nathan J. Zvaifler, MD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1908.
https://doi.org/10.1182/blood.V104.11.1908.1908
Published: 2004